Eiger BioPharmaceuticals

Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million
Xtalks
Mon, 07/15/24 - 11:27 pm
Amylx
GLP-1 agonist
Eiger BioPharmaceuticals
avexitide
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
Clinical Trials Arena
Wed, 07/10/24 - 11:18 am
Amylyx
Relyvrio
clinical trials
avexitide
Eiger BioPharmaceuticals
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
FDA nixes EUA ambitions for Eiger's COVID treatment, proposes full approval pathway instead
Fierce Biotech
Thu, 10/6/22 - 10:52 am
Eiger BioPharmaceuticals
FDA
COVID-19
peginterferon lambda
Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug
Endpoints
Mon, 11/23/20 - 10:11 am
Eiger BioPharmaceuticals
Merck
FDA
progeria
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sun, 03/24/19 - 12:02 pm
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Eiger to seek FDA approval of progeria therapy
BioCentury
Wed, 09/5/18 - 09:10 am
Eiger BioPharmaceuticals
FDA
lonafarnib
progeria